context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. | text | 4997000 | monetaryItemType | text: <entity> 4997000 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. | text | 3339000 | monetaryItemType | text: <entity> 3339000 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 12.5 | percentItemType | text: <entity> 12.5 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 34.6 | percentItemType | text: <entity> 34.6 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 21 | percentItemType | text: <entity> 21 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 4 | percentItemType | text: <entity> 4 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 6 | percentItemType | text: <entity> 6 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 7 | percentItemType | text: <entity> 7 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 1400000 | monetaryItemType | text: <entity> 1400000 </entity> <entity type> monetaryItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 2145000 | monetaryItemType | text: <entity> 2145000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 1032000 | monetaryItemType | text: <entity> 1032000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 229000 | monetaryItemType | text: <entity> 229000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 59849000 | monetaryItemType | text: <entity> 59849000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 56618000 | monetaryItemType | text: <entity> 56618000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 57016000 | monetaryItemType | text: <entity> 57016000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 1306000 | monetaryItemType | text: <entity> 1306000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 2567000 | monetaryItemType | text: <entity> 2567000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 1720000 | monetaryItemType | text: <entity> 1720000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 943000 | monetaryItemType | text: <entity> 943000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 599000 | monetaryItemType | text: <entity> 599000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 1916000 | monetaryItemType | text: <entity> 1916000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 943000 | monetaryItemType | text: <entity> 943000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 8496599 | sharesItemType | text: <entity> 8496599 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 6854092 | sharesItemType | text: <entity> 6854092 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 4715104 | sharesItemType | text: <entity> 4715104 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 365 | sharesItemType | text: <entity> 365 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 26079 | sharesItemType | text: <entity> 26079 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | No | sharesItemType | text: <entity> No </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
The Company operates in one segment, machine vision technology. The Company has a single, company-wide management team that administers operations as a whole rather than as discrete operating segments. The Company’s chief operating decision maker is the chief executive officer, who assesses performance and allocates resources at the corporate level, as compared to the geography, product line, or end market levels. The Company offers a variety of machine vision products that have similar economic characteristics and are distributed by the same sales channels to the same types of customers. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> The Company operates in one segment, machine vision technology. The Company has a single, company-wide management team that administers operations as a whole rather than as discrete operating segments. The Company’s chief operating decision maker is the chief executive officer, who assesses performance and allocates resources at the corporate level, as compared to the geography, product line, or end market levels. The Company offers a variety of machine vision products that have similar economic characteristics and are distributed by the same sales channels to the same types of customers. </context> | us-gaap:NumberOfReportableSegments |
Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
Revenue from a second customer accounted for 11 % of total revenue in 2022. Revenue from this customer was not greater than 10% of total revenue in 2024 or 2023. Accounts receivable from this customer was not greater than 10% of total accounts receivable as of December 31, 2024 or December 31, 2023. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Revenue from a second customer accounted for 11 % of total revenue in 2022. Revenue from this customer was not greater than 10% of total revenue in 2024 or 2023. Accounts receivable from this customer was not greater than 10% of total accounts receivable as of December 31, 2024 or December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 12524000 | monetaryItemType | text: <entity> 12524000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 7065000 | monetaryItemType | text: <entity> 7065000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 6270000 | monetaryItemType | text: <entity> 6270000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 44376245000 | monetaryItemType | text: <entity> 44376245000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 296138000 | monetaryItemType | text: <entity> 296138000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 44227414000 | monetaryItemType | text: <entity> 44227414000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 295144000 | monetaryItemType | text: <entity> 295144000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 148831000 | monetaryItemType | text: <entity> 148831000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 994000 | monetaryItemType | text: <entity> 994000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 38088000 | monetaryItemType | text: <entity> 38088000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 257056000 | monetaryItemType | text: <entity> 257056000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired |
In the fourth quarter of 2024, the Company recorded measurement-period adjustments that increased goodwill by $ 6,478,000 and are reflected in the final purchase price allocation below. The adjustments consisted primarily of changes to deferred income tax liabilities based on the final push-down accounting for intangible assets to legal-entity jurisdictions, a reduction in customer relationships based on a methodology refinement, and changes to provisional assets and liabilities based on new information obtained within the one-year measurement period that refined initial estimates. | text | 6478000 | monetaryItemType | text: <entity> 6478000 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2024, the Company recorded measurement-period adjustments that increased goodwill by $ 6,478,000 and are reflected in the final purchase price allocation below. The adjustments consisted primarily of changes to deferred income tax liabilities based on the final push-down accounting for intangible assets to legal-entity jurisdictions, a reduction in customer relationships based on a methodology refinement, and changes to provisional assets and liabilities based on new information obtained within the one-year measurement period that refined initial estimates. </context> | us-gaap:GoodwillPurchaseAccountingAdjustments |
Transaction costs were approximately $ 5,800,000 and were expensed as incurred as part of SG&A expenses on the Consolidated Statement of Operations. | text | 5800000 | monetaryItemType | text: <entity> 5800000 </entity> <entity type> monetaryItemType </entity type> <context> Transaction costs were approximately $ 5,800,000 and were expensed as incurred as part of SG&A expenses on the Consolidated Statement of Operations. </context> | us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts |
On February 12, 2025, the Company's Board of Directors declared a cash dividend of $ 0.080 per share. The dividend is payable March 13, 2025 to all shareholders of record as of the close of business on February 27, 2025. | text | 0.080 | perShareItemType | text: <entity> 0.080 </entity> <entity type> perShareItemType </entity type> <context> On February 12, 2025, the Company's Board of Directors declared a cash dividend of $ 0.080 per share. The dividend is payable March 13, 2025 to all shareholders of record as of the close of business on February 27, 2025. </context> | us-gaap:DividendsPayableAmountPerShare |
Accounts receivable consist of amounts due from customers for the sales of products and services. The Company reviews its accounts receivable and provides allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. The allowance for doubtful accounts was $ 0.1 million and $ 0.1 million as of December 31, 2024 and 2023, respectively. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Accounts receivable consist of amounts due from customers for the sales of products and services. The Company reviews its accounts receivable and provides allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. The allowance for doubtful accounts was $ 0.1 million and $ 0.1 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent |
The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information | text | 9.8 | monetaryItemType | text: <entity> 9.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company evaluates long-lived assets, such as property and equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, the Company reduces the carrying amount of the assets to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. The Company recorded impairment charges of $ 3.1 million and $ 9.8 million primarily relating to computer equipment, software, right-of-use assets, and intangible assets during the years ended December 31, 2024 and 2023, respectively. There were no impairment losses recorded for the year ended December 31, 2022. Refer to Note 5, Other Financial Statement Information </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 3.9 | monetaryItemType | text: <entity> 3.9 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred. The Company incurred advertising costs of $ 3.9 million, $ 3.3 million and $ 3.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. </context> | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. </context> | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> For entities where the functional currency is the U.S. dollar, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet dates and non-monetary assets and liabilities are remeasured at historical exchange rates. Revenue and expenses are remeasured at the average exchange rates for the period. Gains or losses from foreign currency remeasurement are included in “Other expense, net” in the consolidated statements of operations. The Company recognized foreign currency transaction losses of $ 2.1 million for the year ended December 31, 2024. The Company recognized foreign currency transaction gains of $ 1.2 million and $ 0.2 million for the years ended December 31, 2023 and 2022, respectively. </context> | us-gaap:ForeignCurrencyTransactionGainLossBeforeTax |
On December 7, 2023, the Company committed to a restructuring plan related to the closure of one of its research and development facilities resulting in restructuring charges of $ 2.5 million associated with this plan, comprised primarily of long-lived assets impairment costs and one-time employee termination benefits which were recorded during the year ended December 31, 2023. Restructuring costs of $ 2.5 million were recorded in research and development and general and administrative expenses during the year ended December 31, 2023 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2024. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> On December 7, 2023, the Company committed to a restructuring plan related to the closure of one of its research and development facilities resulting in restructuring charges of $ 2.5 million associated with this plan, comprised primarily of long-lived assets impairment costs and one-time employee termination benefits which were recorded during the year ended December 31, 2023. Restructuring costs of $ 2.5 million were recorded in research and development and general and administrative expenses during the year ended December 31, 2023 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2024. </context> | us-gaap:RestructuringCosts |
On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. | text | 4.2 | monetaryItemType | text: <entity> 4.2 </entity> <entity type> monetaryItemType </entity type> <context> On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. </context> | us-gaap:RestructuringCosts |
On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. </context> | us-gaap:RestructuringCosts |
On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. </context> | us-gaap:RestructuringCosts |
On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> On August 3, 2022, the Company implemented a reduction in force plan in order to decrease costs and maintain a streamlined organization to support the business. Restructuring charges of $ 4.2 million associated with this plan, comprised primarily of severance-related costs, were recorded during the year ended December 31, 2022. Restructuring costs of $ 0.3 million, $ 1.4 million and $ 2.5 million were recorded in cost of revenue, research and development expense, and selling, general and administrative expense, respectively, during the year ended December 31, 2022 in the Company's consolidated statements of operations. The restructuring activities were completed as of December 31, 2022. </context> | us-gaap:RestructuringCosts |
On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. | text | 10.0 | monetaryItemType | text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. </context> | us-gaap:PaymentsToAcquireIntangibleAssets |
On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. | text | 10.0 | monetaryItemType | text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. </context> | us-gaap:AssetAcquisitionConsiderationTransferred |
On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. | text | 15.0 | monetaryItemType | text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> On January 28, 2023, the Company signed an agreement to acquire certain intangible and other assets from Centrillion Technologies, Inc. and Centrillion Technology Holdings Corp. for an upfront cash payment of $ 10.0 million relating to an intellectual property license. Upon the close of the transaction on July 14, 2023, the Company paid additional cash consideration of $ 10.0 million upon acquiring the assets. Under the agreement, the Company is obligated to provide additional cash consideration if certain technology development milestones are met. As of December 31, 2023, the Company had paid $ 21.3 million relating to the completion of development milestones. The Company paid an additional $ 20.0 million in January 2024 in relation to a development milestone which was accrued in the Company's consolidated financial statements as of December 31, 2023. Up to $ 15.0 million of cash consideration is due if an additional technology development milestone is met. Furthermore, the Company expects to pay cash consideration tied to future sales milestones if such milestones are met. </context> | us-gaap:AssetAcquisitionContingentConsiderationLiability |
The transaction was accounted for as an asset acquisition. In connection with this acquisition and milestone payments, the Company acquired an in-process research and development intangible asset of $ 61.0 million during the year ended December 31, 2023 which did not have alternative future use and therefore was recognized as an expense and included as a component of “In-process research and development” in the condensed consolidated statements of operations. The Company also acquired an intangible asset of $ 0.2 million related to assembled workforce which is included in “Intangible assets, net” in the consolidated balance sheets. | text | 61.0 | monetaryItemType | text: <entity> 61.0 </entity> <entity type> monetaryItemType </entity type> <context> The transaction was accounted for as an asset acquisition. In connection with this acquisition and milestone payments, the Company acquired an in-process research and development intangible asset of $ 61.0 million during the year ended December 31, 2023 which did not have alternative future use and therefore was recognized as an expense and included as a component of “In-process research and development” in the condensed consolidated statements of operations. The Company also acquired an intangible asset of $ 0.2 million related to assembled workforce which is included in “Intangible assets, net” in the consolidated balance sheets. </context> | us-gaap:IndefinitelivedIntangibleAssetsAcquired |
The transaction was accounted for as an asset acquisition. In connection with this acquisition and milestone payments, the Company acquired an in-process research and development intangible asset of $ 61.0 million during the year ended December 31, 2023 which did not have alternative future use and therefore was recognized as an expense and included as a component of “In-process research and development” in the condensed consolidated statements of operations. The Company also acquired an intangible asset of $ 0.2 million related to assembled workforce which is included in “Intangible assets, net” in the consolidated balance sheets. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The transaction was accounted for as an asset acquisition. In connection with this acquisition and milestone payments, the Company acquired an in-process research and development intangible asset of $ 61.0 million during the year ended December 31, 2023 which did not have alternative future use and therefore was recognized as an expense and included as a component of “In-process research and development” in the condensed consolidated statements of operations. The Company also acquired an intangible asset of $ 0.2 million related to assembled workforce which is included in “Intangible assets, net” in the consolidated balance sheets. </context> | us-gaap:FinitelivedIntangibleAssetsAcquired1 |
The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized | text | 3.0 | monetaryItemType | text: <entity> 3.0 </entity> <entity type> monetaryItemType </entity type> <context> The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss |
The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss |
The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The company incurred gross realized losses of $ 3.0 thousand and $ 1.7 million, from the sale of available-for-sales debt securities during the years ended December 31, 2024 and 2023, respectively. The Company incurred no material gross realized </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss |
Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 33.9 | monetaryItemType | text: <entity> 33.9 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 32.9 | monetaryItemType | text: <entity> 32.9 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 22.8 | monetaryItemType | text: <entity> 22.8 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 33.9 million, $ 32.9 million and $ 22.8 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. | text | 0.7 | monetaryItemType | text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded impairment charges of $ 2.1 million related to computer equipment and software of which $ 0.3 million, $ 0.7 million and $ 1.1 million was classified in cost of revenue, research and development, and selling, general and administrative expenses, respectively, in the consolidated statement of operations. The impairment charge was triggered by a decision to discontinue a productivity engineering project. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
During the year ended December 31, 2023, the Company recorded impairment charges of $ 4.6 million related to its developed technology and assembled workforce. No impairment losses were recognized for intangible assets during the years ended December 31, 2024 and December 31, 2022. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded impairment charges of $ 4.6 million related to its developed technology and assembled workforce. No impairment losses were recognized for intangible assets during the years ended December 31, 2024 and December 31, 2022. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
During the year ended December 31, 2023, the Company recorded impairment charges of $ 4.6 million related to its developed technology and assembled workforce. No impairment losses were recognized for intangible assets during the years ended December 31, 2024 and December 31, 2022. | text | No | monetaryItemType | text: <entity> No </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded impairment charges of $ 4.6 million related to its developed technology and assembled workforce. No impairment losses were recognized for intangible assets during the years ended December 31, 2024 and December 31, 2022. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. | text | 33.2 | monetaryItemType | text: <entity> 33.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. </context> | us-gaap:RevenueRemainingPerformanceObligation |
As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. | text | 20.7 | monetaryItemType | text: <entity> 20.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. </context> | us-gaap:ContractWithCustomerLiabilityCurrent |
As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. | text | 33.2 | monetaryItemType | text: <entity> 33.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. </context> | us-gaap:ContractWithCustomerLiability |
As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. | text | 22.0 | monetaryItemType | text: <entity> 22.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations related to separately sold extended warranty service agreements, or allocated amounts for extended warranty service agreements bundled with sales of instruments, was $ 33.2 million, of which approximately $ 20.7 million is expected to be recognized to revenue in the next 12 months, with the remainder thereafter. The contract liabilities of $ 33.2 million and $ 22.0 million as of December 31, 2024 and 2023, respectively, consisted of deferred revenue related to extended warranty service agreements. </context> | us-gaap:ContractWithCustomerLiability |
As of December 31, 2024 and 2023, the Company maintained a full valuation allowance on its U.S. net deferred tax assets. The U.S. deferred tax assets predominantly relate to operating losses, tax credits and capitalized R&D intangibles. The U.S. valuation allowance was estimated based on an assessment of both positive and negative evidence to determine whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. The Company’s history of cumulative losses, along with expected future U.S. losses, required that a full valuation allowance be recorded against all U.S. net deferred tax assets. The Company intends to maintain a full valuation allowance on U.S. net deferred tax assets until sufficient positive evidence exists to support a reversal of the valuation allowance. The valuation allowance increased by $ 36.4 million and by $ 78.8 million for the years ended December 31, 2024 and 2023, respectively. | text | 36.4 | monetaryItemType | text: <entity> 36.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company maintained a full valuation allowance on its U.S. net deferred tax assets. The U.S. deferred tax assets predominantly relate to operating losses, tax credits and capitalized R&D intangibles. The U.S. valuation allowance was estimated based on an assessment of both positive and negative evidence to determine whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. The Company’s history of cumulative losses, along with expected future U.S. losses, required that a full valuation allowance be recorded against all U.S. net deferred tax assets. The Company intends to maintain a full valuation allowance on U.S. net deferred tax assets until sufficient positive evidence exists to support a reversal of the valuation allowance. The valuation allowance increased by $ 36.4 million and by $ 78.8 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
As of December 31, 2024 and 2023, the Company maintained a full valuation allowance on its U.S. net deferred tax assets. The U.S. deferred tax assets predominantly relate to operating losses, tax credits and capitalized R&D intangibles. The U.S. valuation allowance was estimated based on an assessment of both positive and negative evidence to determine whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. The Company’s history of cumulative losses, along with expected future U.S. losses, required that a full valuation allowance be recorded against all U.S. net deferred tax assets. The Company intends to maintain a full valuation allowance on U.S. net deferred tax assets until sufficient positive evidence exists to support a reversal of the valuation allowance. The valuation allowance increased by $ 36.4 million and by $ 78.8 million for the years ended December 31, 2024 and 2023, respectively. | text | 78.8 | monetaryItemType | text: <entity> 78.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company maintained a full valuation allowance on its U.S. net deferred tax assets. The U.S. deferred tax assets predominantly relate to operating losses, tax credits and capitalized R&D intangibles. The U.S. valuation allowance was estimated based on an assessment of both positive and negative evidence to determine whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. The Company’s history of cumulative losses, along with expected future U.S. losses, required that a full valuation allowance be recorded against all U.S. net deferred tax assets. The Company intends to maintain a full valuation allowance on U.S. net deferred tax assets until sufficient positive evidence exists to support a reversal of the valuation allowance. The valuation allowance increased by $ 36.4 million and by $ 78.8 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. | text | 638.7 | monetaryItemType | text: <entity> 638.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. | text | 88.5 | monetaryItemType | text: <entity> 88.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. </context> | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. | text | 632.9 | monetaryItemType | text: <entity> 632.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. | text | 424.5 | monetaryItemType | text: <entity> 424.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. </context> | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. | text | 68.3 | monetaryItemType | text: <entity> 68.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had federal net operating loss (NOL) carryforwards of $ 638.7 million and federal tax credit carryforwards of $ 88.5 million. The federal NOL carryforwards generated after December 31, 2017 totaling $ 632.9 million are carried forward indefinitely, while all others, along with the federal tax credit carryforwards, expire in years beginning in 2033. As of December 31, 2024, the Company had state NOL carryforwards of $ 424.5 million, which begin to expire primarily in 2033. In addition, the Company had state tax credit carryforwards of $ 68.3 million, which do not expire. </context> | us-gaap:TaxCreditCarryforwardAmount |
The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. | text | 45.7 | monetaryItemType | text: <entity> 45.7 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized gross tax benefits was $ 50.0 million and $ 45.7 million as of December 31, 2024 and 2023, respectively, of which $ 2.9 million and $ 2.7 million, if recognized, would affect our effective tax rate, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued |
The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued |
The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. | text | 0.7 | monetaryItemType | text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense |
The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense |
The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company includes interest and penalties related to income tax matters within the provision for income taxes. The total amount of gross interest and penalties accrued was $ 1.6 million and $ 0.9 million for the years ended December 31, 2024 and 2023, respectively. The Company recognized interest and penalty expenses of $ 0.7 million, $ 0.5 million and $ 0.2 million in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense |
Company’s behalf and cannot be used by their other customers, the Company is obligated to purchase these components. In addition, certain supplier agreements require the Company to make minimum annual purchases under the agreements. As of December 31, 2024, the Company has commitments to make a total of $ 13.2 million in purchases over the next one year . To date, the Company has met the minimum purchase commitments. | text | 13.2 | monetaryItemType | text: <entity> 13.2 </entity> <entity type> monetaryItemType </entity type> <context> Company’s behalf and cannot be used by their other customers, the Company is obligated to purchase these components. In addition, certain supplier agreements require the Company to make minimum annual purchases under the agreements. As of December 31, 2024, the Company has commitments to make a total of $ 13.2 million in purchases over the next one year . To date, the Company has met the minimum purchase commitments. </context> | us-gaap:PurchaseObligation |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.